Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 71335-2121

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 71335-2121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Fig 1)

This is a graph displaying the mean plasma R-Oxybutynin concentration in ng/mL over time in hours. The comparison is being made between two different doses of Oxybutynin: extended-release tablets of 10mg once daily, and 5mg taken three times a day.*

FDA Label Image

Figure 2 (Fig 2)

Not available. (The text appears to be a sequence of random numbers and few characters that do not form any coherent meaning or description.)*

FDA Label Image

Figure 3 (Figure 3)

FDA Label Image

Figure 4 (Figure 4)

FDA Label Image

Figure 5 (Figure 5)

This is a prescription medication called Oxybutynin chloride, available in the form of extended-release tablets. No further information is available.*

FDA Label Image

Label (Lbl713352121)

This appears to be a medication label for a pack of 30 oxybutynin chloride extended-release tablets. It provides instructions on storing the medication at room temperature and warns to keep the drug out of reach of children. The label also includes the drug's dosage (10mg) and the manufacturer (Unique Pharmaceutical Laboratories).*

FDA Label Image

Rising Logo (Rising Logo)

FDA Label Image

Structure (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.